-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $310 Price Target

Benzinga·05/22/2026 11:03:54
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $310 price target.